Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.538 USD | +4.26% | +17.85% | +96.85% |
Apr. 17 | Brainstorm Cell Therapeutics Inc. Announces Step Down of Stacy Lindborg as Co-CEO, Effective as of May 9, 2024 | CI |
Apr. 17 | Brainstorm Cell Therapeutics Inc. Announces Management Changes | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+96.85% | 35.26M | |
+34.17% | 50.85B | |
+0.63% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.82% | 26.11B | |
-21.65% | 19.13B | |
+9.41% | 13.05B | |
+27.09% | 12.16B | |
+24.13% | 12.08B |
- Stock Market
- Equities
- BCLI Stock
- News Brainstorm Cell Therapeutics Inc.
- Transcript : Brainstorm Cell Therapeutics Inc., Q3 2022 Earnings Call, Nov 14, 2022